Long-acting beta 2-agonists.
Tattersfield
A E
AE
Respiratory Medicine Unit, City Hospital, Nottingham, U.K.
D000318:Adrenergic beta-Agonists / Q000493:pharmacokinetics / Q000494:pharmacology*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D004361:Drug Tolerance; D004983:Ethanolamines / Q000493:pharmacokinetics / Q000494:pharmacology*; D000068759:Formoterol Fumarate; D005569:Formularies as Topic; D006801:Humans; D008137:Longitudinal Studies; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D004983:Ethanolamines; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate